AliveDx
Quotient is a commercial-stage diagnostics company committed to reducing healthcare costs and improving patient care through the provision of innovative tests within established markets. For over 30 years, Quotient customers have trusted the company as a quality provider of reagents for use in blood transfusion medicine. Currently, there are over 40 products licensed for sale in the US and more in the approval and commercialization process. Quotient is developing its proprietary MosaiQ™ platform, with an initial focus on blood grouping and serological disease screening, to offer a breadth of tests that is unmatched by existing commercially available transfusion diagnostic platforms.